Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market by Product (Cell Therapy (Autologous, Allogenic), Gene Therapy, Tissue Engineering (Scaffold, Hydrogels), Application (Musculoskeletal, Oncology, Cardiovascular, Ophthalmology, Wound Care), Region - Global Forecast to 2027" study has been added to ResearchAndMarkets.com's offering.
The regenerative medicine marketplace is projected to scope USD 40.6 Billion by 2027 from USD 12.2 Billion successful 2022, astatine a CAGR of 27.2% during the forecast period.
Market maturation is driven by the availability of backing and rising investments successful R&D, expanding objective trials for stem compartment and CAR-T compartment therapies, and rising advancements successful tissue-engineered products. However, the precocious attraction outgo of RM therapies and commercialization & regulatory are expected to restrain the marketplace maturation during the forecast period.
By application, the musculoskeletal disorders conception accounted for the largest stock of the regenerative medicine market
Based connected applications, the regenerative medicine marketplace is segmented into musculoskeletal disorders, coiled care, oncology, ocular disorders, dental, and different applications. In 2021, the musculoskeletal disorders conception accounted for the largest marketplace share. This tin beryllium attributed to the rising prevalence of orthopedic diseases, the increasing geriatric population, the expanding fig of stem compartment probe projects, the increasing fig of objective research/trials, and the affluent pipeline of stem compartment products for treating musculoskeletal disorders.
Asia Pacific: The fastest-growing portion successful the regenerative medicine market
The Asia Pacific marketplace is projected to turn astatine the highest CAGR during the forecast period, chiefly owed to expanding probe activities successful Asian countries, the availability of backing for research, and the increasing fig of biobanks and probe centers are driving the maturation of the Asia Pacific regenerative medicine market.
North America: the largest stock of the regenerative medicine market
North America accounted for the largest stock of the regenerative medicine market. Factors specified arsenic the to constitution of stem compartment banking, insubstantial engineering , emergence successful request for precocious technology-based treatments similar stem compartment technology, biologics, insubstantial engineering, and biomaterials.
The superior interviews conducted for this study tin beryllium categorized arsenic follows:
- By Respondent: Supply Side- 80% and Demand Side 20%
- By Designation: C-level - 25%, D-level - 20%, and Others - 55%
- By Region: North America -50%, Europe -20%, Asia-Pacific -20%, Latin America -5%, Middle East and Africa - 5%
Report Attribute | Details |
No. of Pages | 192 |
Forecast Period | 2022 - 2027 |
Estimated Market Value (USD) successful 2022 | $12.2 Billion |
Forecasted Market Value (USD) by 2027 | $40.6 Billion |
Compound Annual Growth Rate | 27.2% |
Regions Covered | Global |
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Regenerative Medicine Market, by Product
7 Regenerative Medicine Market, by Application
8 Regenerative Medicine Market, by Region
9 Competitive Landscape
10 Company Profiles
11 Appendix
Companies Mentioned
- 3M Group
- Allergan
- Amgen, Inc.
- Anterogen Co., Ltd.
- APAC Biotech
- Aspect Biosystems
- Bluebird Bio
- Corestem, Inc.
- Integra Lifesciences Holdings Corporation
- Kite Pharma
- Medipost Co., Ltd.
- Medtronic plc
- Mimedx Group
- Misonix
- Novartis Ag
- Organogenesis Inc.
- Orthocell Ltd.
- Shenzhen Sibiono Genetech Co., Ltd.
- Smith & Nephew plc
- Spark Therapeutics
- Stryker Corporation
- Takeda Pharmaceutical Company Limited
- Tego Science, Inc.
- Vericel Corporation
- Zimmer Biomet
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's starring root for planetary marketplace probe reports and marketplace data. We supply you with the latest information connected planetary and determination markets, cardinal industries, the apical companies, caller products and the latest trends.